July 9, 2020 / 11:39 AM / a month ago

BRIEF-Kitov Announces Initiation Of Phase 1/2 Clinical Trial Of NT219 In Advanced Cancer Patients

July 9 (Reuters) - Kitov Pharma Ltd:

* KITOV ANNOUNCES INITIATION OF PHASE 1/2 CLINICAL TRIAL OF NT219 IN ADVANCED CANCER PATIENTS

* KITOV PHARMA LTD - PRELIMINARY DATA FROM FIRST PART OF NT219 STUDY ANTICIPATED TO BE AVAILABLE IN SECOND HALF OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below